The authors report a case of chronic subdural hematoma/effusions (CSDHs) first suspected at 3 months of age after presenting with a seizure, and initially diagnosed as postnatal trauma. However, a close re-examination of fortuitously available serial prenatal ultrasounds clearly establishes the presence of an abnormal, expansive intracranial process already in place by 20-weeks gestation. With no identified prenatal, perinatal, or postnatal trauma, and no identified culpable medical condition as a potential etiology, this case raises the possibility that some, perhaps many or even most CSDHs of infancy can have a congenital etiology.
Introduction
Chronic subdural hematoma/effusion (CSDH) of infancy usually comes to pediatric attention between 2 to 6 months of age. 1, 2 If chronic at the time of diagnosis, no tests exist to place the time of onset or definitively establish the etiology of the CSDH. Head circumference (HC) data from the pediatric record are often the only objective information available to suggest a time for the onset of abnormal head growth. In up to 55% of infants diagnosed with CSDH, there is no culpable medical condition identified, and no recognized history of perinatal or postnatal trauma. 1 Even when history of some trauma is elicited, no episode can be uncritically assumed to be the cause of the problem. However, perinatal or postnatal trauma is routinely presumed.
The following case raises the possibility of an expanded differential to include an in utero etiology for CSDH as simply a congenital malformation without resorting to a presumption of birth trauma or postnatal trauma.
Case
Twin A was the product of a term dichorionic-dizygotic twin pregnancy. The obstetrical records indicated that there was no history of hemophilia, blood disorders or other genetic disorders identified on either side of the family. Conception was via in vitro fertilization. Both twins were delivered vaginally without instrumentation with APGAR 9/9. Estimated blood loss at delivery of the twins was 450 cm 3 . Twin A's hemoglobin level at birth was 19.9 g, and his postnatal bilirubin peaked at 5.5. Both twins were circumcised on day 2 of life with 'minimal bleeding'. Hearing screen and mandated metabolic screening tests were normal. His birth weight was 2934 g (15%Fthe percentile on the growth curve), and his head circumference (HC) measured 35.5 cm (50%). These measurements caused no alarm, although they indicated some head-body disproportion. By 1 month of age, Twin A's weight was 4086 g (50%), his length was 55.9 cm (25%) and his HC was 40 cm (90%). By 2 months, his weight was 5448 g (50%), length was 59.7 cm (25%) and HC was 42.54 cm (>95%). Apart from the suggestion of 'head lag', clinically he was doing well. His parents noted he was the 'crankiest' of their children, and preferred to be upright in 'his' swing. The family referred to him as the twin with the 'big head'. Twin B's birth weight was 3054 g (20%) and his HC measured 33.65 cm (15%). His subsequent growth followed the 30-40th percentile growth curves.
At 3 months of age, Twin A presented to medical attention with 'new onset of partial complex seizure'. At this time, Twin A weighed 5838 g (40%), his HC measured 44 cm (>95%), and his anterior fontanel was noted to be 'bulging, tense'. A photo taken just several days before presentation demonstrated an abnormal appearance in head shape, with bi-parietal bulging and sun-setting sign of the eyes. Retinal hemorrhages were noted by ophthalmology the day after hospital admission.
At the time of diagnosis, his hemoglobin level was 10.2 gFmid-range normal for a 3-month old. Urinalysis, urine organic acid screening and blood chemistries were unremarkable. Blood, urine and subdural fluid cultures were negative. Rotavirus, respiratory syncytial virus and influenza tests were negative. Hepatitis C and HIV tests were negative. Investigation of the integrity of this infant's clotting system revealed a prothrombin time of 10.4 s (9.0-11.5), an international normalized ratio of 0.99 (0.60-1.115), an activated partial thromboplastin time of 28.6 s (21.0-31.0), and a bleeding time of 2.5 min (2.0-9.0).
The initial computed tomography scan revealed diffuse extra-axial low density with no parenchymal abnormalities, and the magnetic resonance image revealed chronic subdural hematomas with small areas of acute blood (Image 1).
Surgical drainage and shunt placement were undertaken. Opening of the dura released 'xanthochromic fluid with some fresh blood' under 'very high pressure'. The estimated blood loss during the placement of the subdural-peritoneal shunt was 5 ml.
On follow-up imaging, the gray/white differentiation was preserved, no cerebral infarction was diagnosed, and the CSDH decreased in size over subsequent months.
Following shunt placement, the infant has done well, with his growth and development comparable to that of his healthy brother. Subsequently, no metabolic or clotting abnormalities have been demonstrated.
Provided these lab results, neuroimaging studies and history, one could easily presume birth or postnatal trauma to be the etiology of this process. Considering that the bulk of the excessive growth occurred in the first month of life, one might be most suspicious of some birth trauma. However, there is no history of perinatal trauma.
The legal dimension of this case prompted close re-evaluation of the records, which included a superb series of prenatal ultrasounds obtained at 20 weeks/5 days, 24 weeks/4 days, 28 weeks/6 days, 32 weeks/6 days and 36 weeks/6 days. These ultrasounds serially document the full growth parameters for each twin (Table 1 and Figure 1 ). 
Congenital chronic SDH
Although these are not identical twins, they are the same sex, and at birth Twin A weighed only 120 g less than Twin BFat the time of Twin A's diagnosis, their weights differed by only 30 g. Moreover, they were subjected to the same variations in intrauterine conditions. Given that Twin B was neurologically normal and demonstrated proportional growth, the availability of this twin provided an opportunity for direct comparison over time. That said, it should be noted that at every point Twin A had the larger bi-parietal diameter and HC, and at every point he had the smaller femoral length compared with his healthy twin; this trend was evident by 20-weeks gestation. Mathematical analysis indicates that this 'head/body' disproportion was accelerating as the pregnancy progressed with no indication of intrauterine growth retardation (Table 1) . By the 32-weeks/6-days ultrasound, Twin A's head was the predicted size for 37 weeks/1 day (Figure 1 ). The serial ultrasound data also reveal that his head was becoming progressively more globular, similar to the changes observed in infant hydrocephalus, while his brother's remained more elongated. By the 36-weeks/6-days ultrasound study, differential geometric approximations based on ultrasound data indicate that Twin A's head was 39% larger by volume than that of his brother, who was healthy by all accounts.
Discussion
Intrauterine subdural hematomas have been occasionally reported. These diagnoses have followed work-ups, prompted by alarming prenatal ultrasound abnormalities, fetal symptoms, known trauma or immediate post-partum clinical findings. [3] [4] [5] However, clinically silent cases of intracranial extra-axial pathology arising in utero would likely go unnoticed until emerging symptoms after birth raised concerns.
There is no evidence that the presence of the CSDH interferes with brain development. Rather, any permanent neurological deficit comes as a consequence of the original trauma that caused the hematoma or from diffuse damage, occurring secondary to increased intracranial pressure and diminished cerebral perfusion. 2 The most common initial symptoms are irritability, vomiting and/or seizures. Macrocranium is common, but not necessarily present. 1 Retinal hemorrhages are present in the majority of cases; before the days of computed tomography scans and magnetic resonance image, the presence of retinal hemorrhages in the absence of well-defined head injury was considered almost pathognomonic for CSDH. 1 Without prenatal magnetic resonance image, this case only establishes the presence in utero of an abnormal intracranial process in place by 20-weeks gestation, expanding to occupy over 25% of the intracranial volume by 37-weeks gestation. However, with no brain pathology demonstrated on neuroimaging, with no evidence of any significant perinatal or postnatal hemorrhage, with no history or evidence of a perinatal or postnatal trauma, and with a clinical unfolding conforming to the classic presentation of an infant with CSDH, it cannot be safely assumed that the CSDH in this case was not already in place by 20-weeks gestation, representing a congenital malformation. To hold the view that every infant enters the delivery room with entirely normal extra-axial spaces seems naïve, when we encounter congenital malformations in most complex organs of the body.
This case also suggests the potential for available prenatal ultrasound imaging to identify worrisome trends in head-body disproportionFbi-parietal diameter/femoral lengthFover the final 2 months of gestation. With cooperation among obstetricians, sonographers, neonatologists and pediatricians, potentially affected infants could be identified and definitively screened after birth with neuroimaging and close pediatric follow-up. This would allow for early intervention before increased intracranial pressure and/or a devastating re-bleed leads to brain infarction or diffuse damage from unrelieved increased intracranial pressure and diminished cerebral perfusion.
